Both in Biotechnology
Tenaya Therapeutics vs Cardiff Oncology
Over the past year TNYA returned −74.0% and CRDF returned −62.9%; their daily moves had a correlation of 0.20.
TNYA −74.0% CRDF −62.9%Growth of $1, one year, split-adjusted
| Metric | TNYA | CRDF |
|---|---|---|
| Price | $0.3725 | $0.8579 |
| Market cap | $84.9M | $66.7M |
| Today | +3.19% | +1.61% |
| 1 month | −34.0% | −24.7% |
| 6 months | −50.6% | −46.7% |
| Year to date | −47.6% | −69.5% |
| 1 year | −74.1% | −63.5% |
| Revenue growth (YoY) | — | −14.0% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −3909.3% | −8882.7% |
| P/E (TTM) | — | — |
| Price / sales | 63.6× | 131.4× |
| Net cash | $78.1M | $34.5M |
| Dividend yield | — | — |
| Volatility (60d) | 78.3% | 71.6% |
| Short % of float | 13.1% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).